Cite
HARVARD Citation
Inase, A. et al. (2023). GSK3 inhibitor enhances gemtuzumab ozogamicin‐induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance. EJHaem. 4 (1), pp. 153-164. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Inase, A. et al. (2023). GSK3 inhibitor enhances gemtuzumab ozogamicin‐induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance. EJHaem. 4 (1), pp. 153-164. [Online].